News Medical2h
Researchers identify new oscillatory patterns in COVID-19 cases across the U.S.
Researchers discovered previously unrecognized oscillatory trends in COVID-19 cases across the U.S., particularly a ...
Pfizer, BioNTech's Omicron-Adapted Covid-19 Vaccine Gets E.U. Marketing Recommendation
Pfizer and BioNTech said on Friday that a committee from the European Medicine Agency recommended marketing authorization for its Omicron adapted vaccine to prevent Covid-19, meaning the vaccine is ...
Booster at least 80% effective against severe Omicron
Even with a booster, protection against severe disease from Omicron may be around 80 to 85.9%, compared to around 97% for ...
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") today announced that the Committee for Medicinal ...
Fears of fast spread of XEC Covid strain after many haven’t had vaccines in long time
Exclusive: Lower levels of protective antibodies could leave the UK population vulnerable to a rapid spread of the XEC Covid ...
EuropaWire1d
Pfizer and BioNTech’s Omicron KP.2-Adapted COVID-19 Vaccine Receives Positive EU Opinion, Awaiting Approval
Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European ...
Invivyd Escapes Investor Suit Over Covid Vaccine Optimism
Invivyd Inc. beat a shareholder lawsuit alleging the biopharma company misled shareholders with optimistic projections about the effectiveness of its Covid-19 treatment against the omicron variant.